The FDA on Friday, July 13, joined more than 20 other countries in recalling medications containing valsartan, an active ingredient used to treat hypertension and heart failure. Some of the medications with valsartan have been contaminated with N-nitrosodimethylamine (NDMA), a probable human carcinogen.

Women and black patients have higher coronary artery bypass grafting (CABG) mortality rates than men and white patients, according to new research published in the Journal of the American Heart Association.

The average blood pressure of American youths is declining, a new CDC report suggests, even as updated guidelines classify almost 800,000 more of them as hypertensive.

A new study, published July 11 in the Journal of the American Medical Association, suggests heart failure (HF) may be moderately hereditary.

A tuberculosis vaccine that has been around for a century is being investigated as a potential low-cost, long-term treatment for type 1 diabetes.

Non-vitamin K antagonist oral anticoagulants may be even more effective for treating women with atrial fibrillation (AFib) than men, suggests a real-world study from Hong Kong published in the Journal of the American College of Cardiology.

Adoption of the new 2017 American College of Cardiology/American Heart Association (ACC/AHA) hypertension guidelines would result in a “substantial” increase in the prevalence of hypertension in both the U.S. and China.

A team of researchers used genome editing to inactivate the PCSK9 protein in the livers of rhesus macaque monkeys, resulting in 30 to 60 percent reductions in LDL cholesterol and even more significant drops in PCSK9 levels.